Copperwynd Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,556
| Closed | -$2.24M | – | 157 |
|
|
2024
Q4 | $2.24M | Buy |
5,556
+576
| +12% | +$232K | 0.62% | 33 |
|
|
2024
Q3 | $2.32M | Buy |
4,980
+474
| +11% | +$220K | 0.7% | 27 |
|
|
2024
Q2 | $2.23M | Sell |
4,506
-272
| -6% | -$135K | 0.73% | 25 |
|
|
2024
Q1 | $2M | Buy |
4,778
+262
| +6% | +$110K | 0.72% | 26 |
|
|
2023
Q4 | $1.84M | Sell |
4,516
-47
| -1% | -$19.1K | 0.73% | 24 |
|
|
2023
Q3 | $1.59M | Sell |
4,563
-48
| -1% | -$16.7K | 0.74% | 24 |
|
|
2023
Q2 | $1.62M | Sell |
4,611
-81
| -2% | -$28.5K | 0.76% | 30 |
|
|
2023
Q1 | $1.48M | Buy |
4,692
+3
| +0.1% | +$945 | 0.76% | 32 |
|
|
2022
Q4 | $1.35M | Buy |
4,689
+166
| +4% | +$47.9K | 0.76% | 31 |
|
|
2022
Q3 | $1.31M | Sell |
4,523
-62
| -1% | -$18K | 0.75% | 28 |
|
|
2022
Q2 | $1.29M | Buy |
+4,585
| New | +$1.29M | 0.76% | 31 |
|